The new company will sell both Mylan’s branded and generic drugs and Pfizer’s off-patent treatments, such as Viagra.
A standout Q2 performance by GSK’s meningitis shot helped offset genericization of off-patent asthma med Advair.
The Swiss drugmaker, which reported an otherwise upbeat second quarter, allocated a substantial reserve to settle bribery charges stemming from the suit.
A report from the IQVIA Institute for Human Data Science identified areas to watch through 2023.
Ding is a nine-year veteran of Astellas.
Wolfe Research analysts say the market is underestimating the vaccine’s potential by more than $2 billion.
Xeomin, made by Merz, is hoping to differentiate itself in a market dominated by Allergan’s Botox.
National ad spend grew 7% year-over-year across all categories and platforms including pharma in October.
Robert Zirkelbach, public affairs EVP at PhRMA, discussed the group’s legislative priorities at the Coalition for Healthcare Communication’s post-election conference on Tuesday.
Please login or register first to view this content.